- Home
- ONC vs LVS Comparison
ONC vs LVS Comparison
Compare ONC & LVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONC
- LVS
- Stock Information
- Founded
- ONC 2010
- LVS 1988
- Country
- ONC Switzerland
- LVS United States
- Employees
- ONC N/A
- LVS N/A
- Industry
- ONC Biotechnology: Pharmaceutical Preparations
- LVS Hotels/Resorts
- Sector
- ONC Health Care
- LVS Consumer Discretionary
- Exchange
- ONC Nasdaq
- LVS Nasdaq
- Market Cap
- ONC 34.8B
- LVS 39.5B
- IPO Year
- ONC N/A
- LVS 2004
- Fundamental
- Price
- ONC $368.19
- LVS $65.73
- Analyst Decision
- ONC Strong Buy
- LVS Buy
- Analyst Count
- ONC 12
- LVS 13
- Target Price
- ONC $361.00
- LVS $64.46
- AVG Volume (30 Days)
- ONC 252.8K
- LVS 6.1M
- Earning Date
- ONC 11-06-2025
- LVS 10-22-2025
- Dividend Yield
- ONC N/A
- LVS 1.53%
- EPS Growth
- ONC N/A
- LVS 9.73
- EPS
- ONC 0.29
- LVS 2.22
- Revenue
- ONC $4,998,489,124.00
- LVS $12,264,000,000.00
- Revenue This Year
- ONC $887.89
- LVS $12.90
- Revenue Next Year
- ONC $22.45
- LVS $5.15
- P/E Ratio
- ONC $1,226.72
- LVS $29.51
- Revenue Growth
- ONC 49.15
- LVS 8.37
- 52 Week Low
- ONC $170.99
- LVS $30.18
- 52 Week High
- ONC $381.50
- LVS $67.83
- Technical
- Relative Strength Index (RSI)
- ONC 66.75
- LVS 71.06
- Support Level
- ONC $306.60
- LVS $61.62
- Resistance Level
- ONC $381.50
- LVS $67.83
- Average True Range (ATR)
- ONC 12.71
- LVS 1.80
- MACD
- ONC 6.69
- LVS 0.50
- Stochastic Oscillator
- ONC 80.96
- LVS 77.12
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
About LVS Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.